Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Progyny (PGNY)

Progyny sets $200 million credit facility, expects Q2 results slightly above guidance

Positive Impact 4 of 5 financing Written later

Progyny entered a $200.0 million revolving credit facility dated July 1, 2025, maturing July 1, 2030. The revolver was undrawn at closing, and the company said it has no planned use for it now. In a July 8 press release, the company also said Q2 2025 revenue, Adjusted net income and Adjusted EBITDA are expected to be slightly above the ranges it gave in May.

Key points

  • $200.0 million revolving loan commitments, undrawn at closing, maturing July 1, 2030
  • Borrowings are secured by substantially all assets and guaranteed by domestic subsidiaries; covenants include a maximum Total Leverage Ratio of 3.50 to 1.00 and a minimum Interest Coverage Ratio of 3.00 to 1.00
  • Q2 2025 revenue, Adjusted net income and Adjusted EBITDA expected slightly above the ranges provided in May
  • Q2 2025 results to be reported after market close on August 7, 2025

The filing

CompanyProgyny (PGNY)
Form8-K, current report
Filed with the SECJul 8, 2025, 8:21 AM ET
Accession number0001551306-25-000153

Items reported: 1.01 Material Definitive Agreement2.02 Results of Operations2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 08, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.